News, events, and resources
Dec 15, 2025
Sterility Assays in Drug and Device Manufacturing
Optimizing the Minimal Required Dilution (MRD) in a cLBA NAb assay improved sensitivity fourfold and drug tolerance fivefold, enhancing ...
Dec 15, 2025
Critical Quality Attribute D0 Impact in ADC Modality
Overview of D0 species in ADCs, compete for target binding, reduce ADC potency, and how they are characterized analytically in development.
Dec 15, 2025
Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality
Overview of ADC components and related CQAs, highlighting how antibody, linker, and payload heterogeneity affect potency, stability and ...
Nov 21, 2025
Strategies for Antibody-Drug Conjugates Bioanalysis
Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ...
Oct 9, 2025
Improving the Sensitivity and Drug Tolerance of a NAb Assay by Optimizing MRD
Optimizing the Minimal Required Dilution (MRD) in a cLBA NAb assay improved sensitivity fourfold and drug tolerance fivefold, enhancing ...
Sep 18, 2025
Representative Pooled Matrix Selection is Critical in ADA Assays
Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays
Sep 18, 2025
A Generic LC-MS/MS Solution for ADC PK Bioanalysis
Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ...
Sep 18, 2025
An immunogenicity analysis strategy to reduce the interference of soluble target proteins
Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ...
Sep 18, 2025
Receptor occupancy of antibody drug measured by flow cytometry
Our experts developed a PD-1 receptor occupancy (RO) assay to monitor drug–target interactions and support pharmacodynamic evaluation in ...
Sep 17, 2025
Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology
Dr. Lorin K. Roskos joins CBS as CSO & Head of Quantitative Clinical Pharmacology (QCP), bringing 30+ years of R&D expertise to ...
Sterility Assays in Drug and Device Manufacturing
Optimizing the Minimal Required Dilution (MRD) in a cLBA NAb assay improved sensitivity fourfold and drug tolerance fivefold, enhancing ...
Critical Quality Attribute D0 Impact in ADC Modality
Overview of D0 species in ADCs, compete for target binding, reduce ADC potency, and how they are characterized analytically in development.
Critical Quality Attribute (CQA) in Antibody Drug Conjugate (ADC) Modality
Overview of ADC components and related CQAs, highlighting how antibody, linker, and payload heterogeneity affect potency, stability and ...
Strategies for Antibody-Drug Conjugates Bioanalysis
Antibody-drug conjugates (ADCs) bioanalysis requires robust methods to track antibodies, payloads, and drug-to-antibody ratio changes in ...
Improving the Sensitivity and Drug Tolerance of a NAb Assay by Optimizing MRD
Optimizing the Minimal Required Dilution (MRD) in a cLBA NAb assay improved sensitivity fourfold and drug tolerance fivefold, enhancing ...
Representative Pooled Matrix Selection is Critical in ADA Assays
Our scientists developed a strategy to reduce false positives and improve the reliability of ADA assays
A Generic LC-MS/MS Solution for ADC PK Bioanalysis
Our experts developed a highly sensitive and specific workflow to quantify total antibodies, conjugated payload, and free payload in ...
An immunogenicity analysis strategy to reduce the interference of soluble target proteins
Our experts established a bioanalytical strategy to eliminate false positive signals caused by soluble drug targets in ADA assays, ...
Receptor occupancy of antibody drug measured by flow cytometry
Our experts developed a PD-1 receptor occupancy (RO) assay to monitor drug–target interactions and support pharmacodynamic evaluation in ...
Dr. Lorin K. Roskos Appointed Chief Scientific Officer and Head of Quantitative Clinical Pharmacology
Dr. Lorin K. Roskos joins CBS as CSO & Head of Quantitative Clinical Pharmacology (QCP), bringing 30+ years of R&D expertise to ...
